Saturday 17 October 2026 Export GOCOQ’s income statement to Excel — free account

GoHealth, Inc.

GoHealth, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $361.8 million, down 54.7% from fiscal 2024. In the quarter to March 2026, revenue fell 94.6%, EPS fell 353.9%, free cash flow grew 145.2% and total debt rose 19.0%, each against the same quarter a year earlier.

0.34 0.00 0.00%

Follow GOCOQ

Alert me

Market cap: $8.5M
P/E: 0.0×
Fwd P/E: −0.1×
Dividend yield: —
F-score: 2/9
Altman Z: n/a
Beneish M: n/a
Dividend safety: n/a

Overview Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	—	—	—	—	—	—	—	—	—	—	—

Insider Ownership 21.09%

Capital & Financial Ratios $m

Market Cap 8.46

Revenue 152.79

Net Income (554.10)

Free Cash Flow (102.56)

Net Debt 762.37

Current Ratio 2.03

Debt/Equity (6.33)

P/E ratio 0.00

Fwd P/E (0.13)

P/S ratio 0.04

P/B ratio 0.00

Past 5Y EPS Growth —

This Y EPS Growth 63.99%

Next Y EPS Growth 47.30%

Next Y revenue growth (27.79%)

Next 5Y EPS Growth 70.08%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2027	Powerpack
2026	Powerpack
2025	Powerpack
2024	Powerpack
2023	Powerpack
2022	Powerpack
2021	Powerpack
2020	Powerpack
2017	Powerpack

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	91	41	33	40
Receivables	336	325	240	215
Inventory	—	—	—	—
Other	—	—	—	—
	476	400	286	265

	2023	2024	2025	Q'26
Payables	18	15	7	8
ST’ Debt	75	40	—	2
Other	6	4	3	3
	370	338	142	130

Compound Annual Growth %

	10y	5y	3y
Sales	—	(16.23%)	(16.95%)
Cash Flow	—	0.00%	0.00%
Earnings	—	0.00%	0.00%
Book Value	—	0.00%	0.00%

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	12	—	—	—	—
’25	221	94	34	13	362
’24	186	106	118	389	799
’23	183	143	132	277	735
’22	271	159	133	69	632
’21	204	197	212	450	1,062
’20	141	127	163	446	877

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	7	—	—	—	—
’25	(12)	(38)	(33)	(39)	(122)
’24	13	(36)	(12)	15	(22)
’23	20	11	7	71	109
’22	54	(48)	96	(41)	61
’21	31	(63)	(40)	(227)	(299)
’20	24	(28)	33	(143)	(114)

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	7	—	—	—	—
’25	(15)	(41)	(35)	(39)	(130)
’24	8	(39)	(16)	12	(35)
’23	18	8	3	66	95
’22	48	(52)	93	(42)	47
’21	27	(68)	(52)	(227)	(319)
’20	20	(32)	29	(146)	(129)

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	(2.36)	—	—	—	—
’25	(0.52)	(5.10)	(11.80)	(1.03)	(20.17)
’24	(1.04)	(2.70)	0.46	1.56	(0.66)
’23	(1.12)	(3.27)	(2.61)	(0.22)	(7.19)
’22	(1.80)	(5.25)	(3.45)	(7.00)	(17.72)
’21	(0.30)	(1.80)	(2.70)	(20.24)	(26.84)
’20	0.00	(3.52)	(9.75)	1.68	(3.30)

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	—	—	—	—	150.15	49.20	4.94	7.05	7.27	2.05	Analyst estimates 2026–2028 Powerpack
	High	—	—	—	—	393.75	245.50	63.60	22.85	14.80	21.00
People
People	Employees	—	—	—	1,857	3,067	5,448	2,467	2,530	2,261	850
	Revenue/emp, $m	—	—	0.00	0.29	0.29	0.20	0.26	0.29	0.35	0.43
Income, $m
Income, $m	Revenue	—	—	226	540	877	1,062	632	735	799	362
	Gross margin, %	—	—	64.82	68.57	77.30	77.47	70.29	78.36	83.65	73.43
	EBT	—	—	28	(41)	(97)	(534)	(376)	(151)	(5)	(501)
	EBT margin, %	—	—	12.45	(7.62)	(11.07)	(50.28)	(59.46)	(20.57)	(0.63)	(138.48)
	Net income	—	0	28	(41)	(97)	(534)	(376)	(151)	(7)	(498)
	Depreciation	—	—	6	33	101	496	110	109	115	88
Per share, $
Per share, $	Revenue	—	—	37.70	0.00	156.33	150.36	74.80	79.06	80.05	27.96
	Earnings	—	—	5.01	(7.32)	(3.30)	(26.84)	(17.72)	(7.19)	(0.66)	(20.17)
	Cash flow	—	—	0.91	0.00	(20.35)	(42.32)	7.21	11.75	(2.16)	(9.42)
	Capex	—	—	(1.03)	0.00	(2.59)	(2.80)	(1.60)	(1.48)	(1.38)	(0.64)
	Free cash flow	—	—	(0.12)	0.00	(22.94)	(45.12)	5.61	10.27	(3.54)	(10.06)
	Book value	—	—	0.00	0.00	249.31	126.31	64.23	43.66	40.63	(4.81)
	Shares, m	—	—	6	0	6	7	8	9	10	13
Valuation, ×
Valuation, ×	P/E	—	—	1,946.00	1,946.00	0.00	0.00	0.00	0.00	0.00	0.00
	P/S	—	—	0.00	0.00	1.31	0.38	0.14	0.17	0.17	0.08
	P/B	—	—	4.59	4.59	0.82	0.45	0.16	0.30	0.33	0.00
	EV/Sales	—	—	0.00	0.00	1.81	1.19	1.32	1.00	0.95	2.29
	EV/FCF	—	—	(87.48)	(87.48)	(12.35)	(3.96)	17.56	7.67	(21.44)	(6.36)
Cash, $m
Cash, $m	Operating cash flow	—	—	5	0	(114)	(299)	61	109	(22)	(122)
	Capex	—	—	(6)	(8)	(15)	(20)	(14)	(14)	(14)	(8)
	Free cash flow	—	—	(1)	(8)	(129)	(319)	47	95	(35)	(130)
Balance, $m
Balance, $m	Working capital	—	—	—	31	264	212	149	106	62	144
	Total debt	—	—	5	389	583	945	763	701	665	793
	Net debt	—	—	4	376	439	860	747	610	624	760
	Shareholders’ equity	—	—	—	860	1,399	892	542	406	405	(62)
Returns, %
Returns, %	ROA	—	—	0.00	(5.13)	(1.01)	(9.07)	(8.03)	(4.23)	(0.44)	(21.09)
	ROIC	—	—	449.42	(1.66)	(2.19)	(17.45)	(15.45)	(5.03)	(0.43)	(36.96)
	ROE	—	—	44.63	(12.20)	(1.66)	(16.53)	(20.86)	(14.10)	(1.62)	(152.11)

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Mar 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
CRD.B Crawford & Company	$581.0M	24.4×	11.9×	−1.37% (below 0%: shrinking)	+75.00% (above 0%: growing)	−51.68% (below 0%: shrinking)	28.78%	7.68%	Compare
XHG XChange TEC.INC. Sponsored ADR	$78.8M	— (loss-making)	— (loss-making)	−69.19% (below 0%: shrinking)	n/m	−324.48% (below 0%: shrinking)	0.00%	0.00%	Compare
AIFU AIFU Inc. - Sponsored ADR	$67.1M	0.0×	11.0×	−15.11% (below 0%: shrinking)	n/m	−96.62% (below 0%: shrinking)	36.32%	2.74%	Compare
SLQT SelectQuote, Inc.	$60.9M	— (loss-making)	— (loss-making)	−6.79% (below 0%: shrinking)	n/m	+80.58% (above 0%: growing)	32.15%	1.07%	Compare
EHTH eHealth, Inc.	$19.4M	— (loss-making)	— (loss-making)	−44.78% (below 0%: shrinking)	n/m	+83.77% (above 0%: growing)	100.00%	(81.80%)	Compare
HUIZ Huize Holding Limited Sponsored ADR	$12.3M	57.7×	— (loss-making)	+42.24% (above 0%: growing)	n/m	−115.73% (below 0%: shrinking)	27.47%	3.61%	Compare
ZBAO Zhibao Technology Inc.	$8.5M	—	—	—	—	−1,040.72% (below 0%: shrinking)	—	—	Compare
GOCOQ GoHealth, Inc.	$8.5M	— (loss-making)	— (loss-making)	−94.61% (below 0%: shrinking)	n/m	+145.21% (above 0%: growing)	30.18%	(292.04%)
TIRXF Tian Ruixiang Holdings Ltd.	$5.7M	— (loss-making)	— (loss-making)	−55.71% (below 0%: shrinking)	+79.08% (above 0%: growing)	−456.76% (below 0%: shrinking)	0.00%	0.00%	Compare
Median of peers	$40.1M	24.4×	—	−15.11%	—	−106.17%	28.78%	1.07%

All 22 Insurance Brokers stocks →

GoHealth, Inc. (GOCOQ) key facts

Concern: GoHealth, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $361.8 million, down 54.7% from fiscal 2024.
GoHealth, Inc. (GOCOQ) is an Insurance Brokers company in the Financial sector.
As of July 28, 2026, GOCOQ traded at $0.34, a market capitalization of $8.5 million.
Return on equity was −152.1% and debt-to-equity -6.33.
Its Piotroski F-score is 2 out of 9 for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.